Literature DB >> 17620963

Baroreflex sensitivity correlates with left ventricular morphology and diastolic function in essential hypertension.

Alberto Milan1, Mimma A Caserta, Sara Del Colle, Antonio Dematteis, Fulvio Morello, Franco Rabbia, Paolo Mulatero, Natesa G Pandian, Franco Veglio.   

Abstract

OBJECTIVES: Arterial hypertension is a common cause of cardiac organ damage, inducing morphological and functional modifications. Spontaneous baroreflex sensitivity (BRS) control of the heart rate is a key mechanism of blood pressure homeostasis, and is impaired in patients with hypertension. This study sought to assess the association between BRS and left ventricular morphology and function.
METHODS: We studied 224 hypertensive patients (125 men; aged 47.8 +/- 10.8 years, mean +/- SD) compared with 51 normotensive control subjects (25 men, aged 45.7 +/- 12.5 years). Left ventricular morphology, systolic and diastolic function were evaluated by echocardiography. Spontaneous BRS was measured using the sequence method.
RESULTS: BRS was inversely associated with relative wall thickness (R = 0.17; P < 0.0001) and left ventricular mass index (R = 0.03; P = 0.01); in particular, BRS was significantly impaired in patients with concentric left ventricular remodelling (median [interquartile difference] 9.4 [4.1]) and hypertrophy (9.05 [3.9]) compared with the normal left ventricle (12.3 [5]; P < 0.001). BRS showed a significant association with systolic function evaluated by midwall fractional shortening (r = 0.28; P < 0.001), stroke volume (r = 0.27; P < 0.001), stroke work (r = 0.17; P < 0.05), and fractional shortening (r = 0.17; P < 0.05). BRS was significantly decreased in patients with diastolic dysfunction; it was lower in patients with diastolic dysfunction compared with both the control group and hypertensive patients with normal diastolic function.
CONCLUSION: BRS is associated with left ventricular morphology, systolic and diastolic function in hypertensive patients. In particular BRS is impaired in patients with diastolic dysfunction. These findings suggest a role for BRS as a target in arterial hypertension.

Entities:  

Mesh:

Year:  2007        PMID: 17620963     DOI: 10.1097/HJH.0b013e3281ddb0a0

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 2.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

Review 3.  Anti-hypertensive drugs and left ventricular hypertrophy: a clinical update.

Authors:  Alberto Milan; Mimma A Caserta; Eleonora Avenatti; Sara Abram; Franco Veglio
Journal:  Intern Emerg Med       Date:  2010-05-18       Impact factor: 3.397

4.  Cystathionine-γ lyase-derived hydrogen sulfide mediates the cardiovascular protective effects of moxonidine in diabetic rats.

Authors:  Shaimaa S El-Sayed; Mohamed N M Zakaria; Rasha H Abdel-Ghany; Abdel A Abdel-Rahman
Journal:  Eur J Pharmacol       Date:  2016-04-29       Impact factor: 4.432

Review 5.  Orthostatic hypertension-a new haemodynamic cardiovascular risk factor.

Authors:  Kazuomi Kario
Journal:  Nat Rev Nephrol       Date:  2013-11-05       Impact factor: 28.314

6.  Central Pressure Appraisal: Clinical Validation of a Subject-Specific Mathematical Model.

Authors:  Francesco Tosello; Andrea Guala; Dario Leone; Carlo Camporeale; Giulia Bruno; Luca Ridolfi; Franco Veglio; Alberto Milan
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

7.  Morning hypertension assessed by home monitoring is a strong predictor of concentric left ventricular hypertrophy in patients with untreated hypertension.

Authors:  Yoshio Matsui; Kazuo Eguchi; Seiichi Shibasaki; Joji Ishikawa; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-10       Impact factor: 3.738

8.  Early Left Ventricular Diastolic Dysfunction, Reduced Baroreflex Sensitivity, and Cardiac Autonomic Imbalance in Anabolic-Androgenic Steroid Users.

Authors:  Evangelia Joseph Kouidi; Antonia Kaltsatou; Maria Apostolos Anifanti; Asterios Pantazis Deligiannis
Journal:  Int J Environ Res Public Health       Date:  2021-06-29       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.